Stay updated with breaking news from Electrad Paskett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Clinical trials for cancer control and treatment typically have very few patients from non-White backgrounds, but a multipronged approached has increased participation of underrepresented patients.
Cancer screenings rapidly decreased during the COVID-19 pandemic as health care practices considered not urgent came to a halt.
Experts point out that a lack of diversity in cancer trials is a key factor influencing disparities and inequities in cancer care and cancer outcomes.
Experts point out that a lack of diversity in cancer trials is a key factor influencing disparities and inequities in cancer care and cancer outcomes.
The Alliance for Clinical Trials in Oncology, in partnership with the National Cancer Institute, part of the National Institutes of Health, today announced the opening of a new study for participant enrollment that aims to obtain a reference set of blood samples from newly diagnosed patients with cancer and healthy individuals without cancer to include in a future study to assess the utility of early cancer detection blood tests.